Discovery of New Fusion Transcripts in a Cohort of Pediatric Solid Cancers at Relapse and Relevance for Personalized Medicine

Author:

Dupain Célia,Harttrampf Anne C.,Boursin Yannick,Lebeurrier Manuel,Rondof Windy,Robert-Siegwald Guillaume,Khoueiry Pierre,Geoerger Birgit,Massaad-Massade Liliane

Funder

French National Research Agency

Fondation Gustave Roussy

Fondation Philantropia

Université Paris-Sud

CNRS

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference70 articles.

1. The emerging complexity of gene fusions in cancer;Mertens;Nat. Rev. Cancer,2015

2. Cancer genes generated by rare chromosomal rearrangements rather than activation of oncogenes;Duesberg;Med. Oncol. Tumor Pharmacother.,1987

3. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia;Druker;N. Engl. J. Med.,2001

4. Infantile Fibrosarcoma With NTRK3-ETV6 Fusion Successfully Treated With the Tropomyosin-Related Kinase Inhibitor LOXO-101;Nagasubramanian;Pediatr. Blood Cancer,2016

5. Transforming fusions of FGFR and TACC genes in human glioblastoma;Singh;Science,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3